Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,630 total articles

Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study

Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study

BriaCell Therapeutics announced that the independent Data Safety Monitoring Board (DSMB) has recommended continuing the company's pivotal Phase 3 trial of Bria-IMT combined with an immune checkpoint inhibitor for metastatic breast cancer. This marks the seventh consecutive positive DSMB review, indicating no safety concerns and reinforcing the favo…

Bowman Consulting Group Announces Expiration of “Go-Shop” Period

Bowman Consulting Group Announces Expiration of “Go-Shop” Period

Bowman Consulting Group has announced the expiration of the 'go-shop' period related to its planned acquisition by Bernhard Capital Partners. During this period, no competing bids emerged despite active solicitation, affirming Bernhard's all-cash offer of $43.00 per share, representing a 58% premium over the unaffected stock price. The acquisition …

Caliber Completes $3.4 Million Refinance of Corporate Notes and Secures the Right to Retire an Additional $9.1 Million at a Discount

Caliber Completes $3.4 Million Refinance of Corporate Notes and Secures the Right to Retire an Additional $9.1 Million at a Discount

Caliber, a real estate-focused alternative asset manager, has completed refinancing $3.4 million of its corporate notes with longer-term amortizing notes and converted $0.6 million into convertible preferred stock, reducing annual interest expenses. Furthermore, the company secured agreements allowing it to retire an additional $9.1 million of note…

American Battery Technology Company Reports FY 26 Financial Results, Delivering 407% Revenue Growth and Positive Adjusted Gross Profit

American Battery Technology Company Reports FY 26 Financial Results, Delivering 407% Revenue Growth and Positive Adjusted Gross Profit

American Battery Technology Company (NASDAQ: ABAT) announced its fiscal year 2026 financial results, delivering a 407% revenue increase to $21.7 million and achieving positive adjusted gross profit of $1.7 million. The company advanced its domestic lithium-ion battery recycling facilities, including ramping its first commercial-scale operation and …

Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm

Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm

Beta Bionics announced FDA clearance for its innovative Mint patch pump and submitted its next-generation insulin dosing algorithm, 3D Intelligence, for FDA review. Full commercialization of Mint is expected in Q1 2027 with manufacturing capacity to produce at least 1.5 million units in 2027. 3D Intelligence aims to offer personalized insulin deliv…

SL Green’s 2026 Office Leasing Reaches Nearly 1.8 Million Square Feet

SL Green’s 2026 Office Leasing Reaches Nearly 1.8 Million Square Feet

SL Green Realty Corp., Manhattan’s largest office landlord, announced leasing of 1.76 million square feet of office space in 2026 so far, achieving a 15.8% increase in rents versus prior leases. The company also has over 1 million square feet in its current leasing pipeline, with several key tenants renewing or expanding leases, demonstrating stron…

Edible Garden Showcases the Farm-to-Formula® Future of Clean Nutrition and Ready-to-Drink Innovation at ECRM

Edible Garden Showcases the Farm-to-Formula® Future of Clean Nutrition and Ready-to-Drink Innovation at ECRM

Edible Garden AG Inc., a Nasdaq-listed leader in controlled environment agriculture and sustainable produce, is showcasing its expanding clean nutrition and ready-to-drink (RTD) products at the ECRM Vitamin, Weight Management & Sports Nutrition session. The company is promoting its Farm-to-Formula® strategy, leveraging its traditional produce busin…

Hub Group Announces Select Preliminary First and Second Quarter 2026 Financial Results and Provides Update on Restatement Process

Hub Group Announces Select Preliminary First and Second Quarter 2026 Financial Results and Provides Update on Restatement Process

Hub Group, Inc. released preliminary unaudited financial results for the first half of 2026, highlighting revenue in line with expectations but operating losses due to increased costs and accounting restatement-related expenses. The company is undergoing an extensive financial statement restatement process, which has delayed SEC filings and led Nas…

Highwoods Announces Leasing and Disposition Activity

Highwoods Announces Leasing and Disposition Activity

Highwoods Properties announced signing 1.1 million square feet of second generation leases in Q3 2026, including over 200,000 square feet of new leases, reflecting robust leasing demand. The company closed $74 million in non-core disposals, part of its strategic asset sales totaling $374.8 million this year, aimed at optimizing portfolio and improv…

Cullinan Therapeutics to Host Virtual Analyst and Investor Event Today to Feature Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer

Cullinan Therapeutics to Host Virtual Analyst and Investor Event Today to Feature Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer

Cullinan Therapeutics announced a virtual event to present interim Phase 3 REZILIENT3 trial data of zipalertinib plus chemotherapy in lung cancer, recently featured at the IASLC 2026 World Conference on Lung Cancer. The data, presented in a Presidential Symposium, highlights potential advancement in T cell engager therapeutics for cancer treatment.

Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference

Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference

Pasithea Therapeutics announced it will present initial clinical data from Part A of its ongoing Phase 1/1b trial of PAS-004, a novel oral MEK inhibitor for neurofibromatosis type 1 (NF1)-associated neurofibromas, at the 2026 European Neurofibromatosis Conference in Vienna. This marks the company's first public disclosure of clinical data for the d…

Village Farms Appoints Deepak Anand to Lead Global Government Affairs

Village Farms Appoints Deepak Anand to Lead Global Government Affairs

Village Farms International has appointed Deepak Anand as Vice President of Government Affairs to lead global government relations and regulatory strategies. Anand's extensive experience in cannabis policy and international market development is expected to strengthen Village Farms' position and expansion in global cannabis markets. This strategic …

Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma

Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma

Immunocore Holdings plc announced the successful enrollment of 540 patients in its registrational Phase 3 TEBE-AM trial assessing KIMMTRAK (tebentafusp) in previously treated patients with HLA-A*02:01-positive advanced melanoma. The trial evaluates KIMMTRAK as monotherapy and in combination with pembrolizumab against Investigator’s Choice, with ove…

GeNeuro, Inc., an NRx Company (Nasdaq:NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis (ALS)

GeNeuro, Inc., an NRx Company (Nasdaq:NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis (ALS)

GeNeuro, a US subsidiary of NRx Pharmaceuticals (Nasdaq: NRXP), announced the award of a European patent for GNK-301, a monoclonal antibody targeting the HERV K Envelope protein implicated in ALS. The patent complements two US patents and supports the technology to potentially modify ALS progression. GNK-301 manufacturing under cGMP is underway, wi…

UMH PROPERTIES, INC. WILL ATTEND AND SHOWCASE TWO HOMES AT THE U.S. DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT’S ANNUAL INNOVATIVE HOUSING SHOWCASE

UMH PROPERTIES, INC. WILL ATTEND AND SHOWCASE TWO HOMES AT THE U.S. DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT’S ANNUAL INNOVATIVE HOUSING SHOWCASE

UMH Properties, Inc., a US-based REIT specializing in manufactured home communities, will present two innovative manufactured homes at the U.S. Department of Housing and Urban Development's annual Innovative Housing Showcase for the sixth year. The featured homes demonstrate advanced design and construction techniques enhancing affordable housing o…

Ashland Innovation Day to be held September 17, 2026

Ashland Innovation Day to be held September 17, 2026

Ashland Inc. will host an Innovation Day webcast on September 17, 2026, where company leadership will present updated information on their innovative technology platforms, commercial progress, and scalability. The event aims to showcase advancements poised to impact key markets such as architectural coatings, construction, energy, food and beverage…

Osisko Gold Announces Formal Construction Decision and Development Update for the Cariboo Gold Project

Osisko Gold Announces Formal Construction Decision and Development Update for the Cariboo Gold Project

Osisko Gold Group Inc. has officially approved the construction of its 100%-owned Cariboo Gold Project in British Columbia, targeting first gold production in Q1 2029 and commercial production by H2 2029. The project is supported by a $30 million strategic private placement and offtake agreements with Trafigura, along with a potential $120 million …

AirJoule Technologies Acquires BitSink, Adding Profitable AI & HPC Infrastructure Cooling Business

AirJoule Technologies Acquires BitSink, Adding Profitable AI & HPC Infrastructure Cooling Business

AirJoule Technologies Corporation has acquired BitSink, a U.S.-based company specializing in cooling and power distribution infrastructure for AI and high-performance computing data centers. This acquisition positions AirJoule as a broader infrastructure solutions provider, addressing critical constraints such as cooling, water, and power for next-…